Records containing: Uveitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-07-02Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
-
CLINICAL_TRIALS study record update · 2017-07-02Use of Immune Cell Markers, Cytokines, Transcription Factors and Surface CD Markers as Markers of Ocular Inflammatory Activity
-
CLINICAL_TRIALS study record update · 2017-07-02Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Ocular Inflammatory or Immunologic Diseases
-
CLINICAL_TRIALS study record update · 2017-07-02Analysis of Differential Gene Expression Profiles in Patients With Defined Ocular Inflammatory Diseases Using CDNA Microarrays and Proteomics
-
CLINICAL_TRIALS study record update · 2017-07-02Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-07-02Trial of Treatment of Non-Infectious Intermediate and Posterior Uveitis With Humanized Anti-Tac Antibody Therapy
-
CLINICAL_TRIALS study record update · 2017-07-02Combination Daclizumab/Sirolimus Therapy For the Induction of Immune Tolerance in Non-Infectious Intermediate and Posterior Uveitis
-
CLINICAL_TRIALS study record update · 2017-07-02Ocular and Immuno-Genetic Manifestations of Sarcoidosis
-
CLINICAL_TRIALS study record update · 2017-06-20A Randomized, Double-Masked and Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sarilumab Administered Subcutaneously Every 2 Weeks in Patients With Non-Infectious, Intermediate, Posterior or Pan-Uveitis (NIU)
-
CLINICAL_TRIALS study record update · 2017-04-25ClinicalTrials.gov study NCT00956124
-
CLINICAL_TRIALS study record update · 2016-11-29A Randomized, Double-Masked, Parallel Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Uveitis Associated Macular Edema
-
CLINICAL_TRIALS study record update · 2016-10-17ClinicalTrials.gov study NCT02934841
-
CLINICAL_TRIALS study record update · 2016-08-22A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis - Including a Sub-study in Japanese Patients
-
CLINICAL_TRIALS study record update · 2016-07-12A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
-
CLINICAL_TRIALS study record update · 2016-06-21A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis - Including a Sub-study in Japanese Patients
-
CLINICAL_TRIALS study record update · 2016-04-08A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis
-
CLINICAL_TRIALS study record update · 2016-02-22A 38-week Extension to a 24 Week Multicenter, Randomized, Double-masked, Placebo Controlled Study to Assess the Difference in the Rate of Recurrent Exacerbations in Behçet's Patients With Posterior or Panuveitis Treated With AIN457 vs Placebo Adjunctive to Standard-of-care Immunosuppressive Therapy (SHIELD Study)
-
CLINICAL_TRIALS study record update · 2016-01-05First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial
-
CLINICAL_TRIALS study record update · 2015-12-03Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
-
CLINICAL_TRIALS study record update · 2015-11-18Retinal Nerve Fibre Layer in Uveitic Secondary Glaucoma
-
CLINICAL_TRIALS study record update · 2015-11-03A 28-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study to Assess AIN457 Versus Placebo in Inducing and Maintaining Uveitis Suppression in Adults With Active, Non-infectious, Intermediate, Posterior or Panuveitis Requiring Immunosuppression (INSURE Study)
-
CLINICAL_TRIALS study record update · 2015-10-16An Open-Label, Non-Randomized, Single-Arm, Rollover Study to Continue Dosing of Gevokizumab in Subjects With Non Infectious Intermediate-, Posterior-, or Pan-Uveitis Patients Who Each Successfully Completed Either the X052130/CL3-78989-005 (EYEGUARD™-A) or the X052131/CL3-78989-006 (EYEGUARD™-C) Study or Who Have Controlled Ocular Inflammation After Receiving Study Drug in Study X052133 (EYEGUARD™-US)
-
CLINICAL_TRIALS study record update · 2015-05-27Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
-
CLINICAL_TRIALS study record update · 2015-03-11TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
-
CLINICAL_TRIALS study record update · 2014-12-11Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids Following a Periocular Steroid Injections in Patients on Steroid Sparing Agents or Low Dose Steroids